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Abstract
Background: medication-related problems occur frequently when older patients are discharged from hospital. Interventions
to support medication use have been developed; however, their eﬀectiveness in older populations are unknown. This review
evaluates interventions that support successful transitions of care through enhanced medication continuity.
Methods: a database search for randomised controlled trials was conducted. Selection criteria included mean participant age
of 65 years and older, intervention delivered during hospital stay or following recent discharge and including activities that
support medication continuity. Primary outcome of interest was hospital readmission. Secondary outcomes related to the safe
use of medication and quality of life. Outcomes were pooled by random-eﬀects meta-analysis where possible.
Results: twenty-four studies (total participants= 17,664) describing activities delivered at multiple time points were included.
Interventions that bridged the transition for up to 90 days weremore likely to support successful transitions.Themeta-analysis,
stratiﬁed by intervention component, demonstrated that self-management activities (RR 0.81 [0.74, 0.89]), telephone follow-
up (RR 0.84 [0.73, 0.97]) and medication reconciliation (RR 0.88 [0.81, 0.96]) were statistically associated with reduced
hospital readmissions.
Conclusion: our results suggest that interventions that best support older patients’ medication continuity are those that
bridge transitions; these also have the greatest impact on reducing hospital readmission. Interventions that included self-
management, telephone follow-up and medication reconciliation activities were most likely to be eﬀective; however, further
research needs to identify how to meaningfully engage with patients and caregivers to best support post-discharge medication
continuity. Limitations included high subjectivity of intervention coding, study heterogeneity and resource restrictions.
Keywords:medication management, systematic review, continuity of care, hospital discharge, older people
Key points
• Medication-related problems occur frequently when older patients are discharged from hospital.
• Interventions that best support older patients’ medication continuity are those that bridge transitions.
• Interventions that included self-management, telephone follow-up and medication reconciliation activities were most
eﬀective.
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Introduction
Medication management processes and behaviours support
safe and eﬀective medication use. These involve health-
care professionals, caregivers, organisations and the patient
themselves. Medication-related problems (MRPs) and inter-
ruptions to, or discontinuity of, medication management
occur frequently when older patients are discharged from
hospital [1–4]. MRPs can lead to hospital readmission and
poorer quality of life (QoL), resulting in higher healthcare
utilisation [5, 6]. Speciﬁc problems include reconciliation
errors [7], patient confusion [3], inappropriate continuation
of short-termmedication [8] and inadequatemonitoring [9].
Better and safer care transitions, especially hospital dis-
charge, are an international priority [10–12]. Burke et al .’s
ideal transition-of-care framework [12] recognises medica-
tion safety as a crucial element for successful transitions.
Evaluation of interventions to support medication continu-
ity indicated that patient education at discharge reduced the
risk of adverse medication-related events, although evidence
remains limited [13]. An American study further highlighted
the value of pharmacy-supported interventions in reducing
hospital readmissions [14]. However, neither of these studies
evaluated the eﬀectiveness of interventions delivered speciﬁ-
cally to older populations.
Other systematic reviews have identiﬁed discharge inter-
ventions that reduce negative patient outcomes; however,
their focus was broader than medications [15, 16]. Eval-
uation of complex interventions, deﬁned as those involv-
ing multiple components, outcomes, target behaviours or
ﬂexibility [17] is notoriously diﬃcult [18, 19]. To address
this, Leppin and colleagues (building on work of Hansen
et al . [16]) developed a taxonomy of interventional compo-
nents allowing in-depth comparison and meta-analysis [15].
Guidance published in 2000 by the UK’s Medical Research
Council (MRC), who invest in research, also established an
inﬂuential good practice framework [17] to help overcome
evaluation challenges.
This review aims to build on this previous knowledge
by evaluating interventions, aimed at supporting successful
transitions of care for older patients through enhanced med-
ication continuity, using a taxonomy of components.
Methods
To promote rigour and transparency, the Preferred Reporting
Items for Systematic Reviews and Meta-analyses (PRISMA)
checklist is presented (Supplementary Material A1) and the
review is registered [PROSPERO (CRD42018086873)].
Search strategy
Published studies from 1st January 2003 to 1st Septem-
ber 2019 were sought from electronic databases (MED-
LINE, EMBASE, CINAHL, PsycINFO, clinicaltrials.gov
and Cochrane Database of Systematic Reviews). The start
date of 2003 was chosen to coincide with predicted uptake of
MRC guidance by researchers, as demonstrated byDatta and
Petticrew [18], and therefore its subsequent implementation
within trials.
Medical Subject Headings chosen in collaboration with
a subject librarian, including key search terms related to
care transitions (e.g. transitional care, patient handoﬀ and
discharge), were combined with those related to medication
continuity (e.g. pharmacy services, medication systems and
safety) (see Supplementary Material A2). Additional cita-
tions were identiﬁed through hand-searching reference lists
and forward citation search. English language restrictions
were imposed due to time and resource limitations.
Selection criteria
Inclusion and exclusion criteria
Eligible studies included participants with a mean age of
65 years or older, who were being prepared for hospital
discharge or who had a recent discharge (intervention pro-
vided within 1 month of discharge or on ﬁrst post-discharge
primary care visit). Study interventions had to describe
activities relating to medication that supported continuity.
Outcomes of successful transitions were of interest; primarily
a reduction in hospital readmission rates. Secondary out-
comes relating to the safe use of medication (e.g. MRPs
and discrepancies) and QoL were also included as these
factors contribute to successful transitions and can be medi-
ated through medication continuity. The search was limited
to randomised controlled trials (RCT) and cluster RCT
(cRCT) as these are considered the gold standard in the
hierarchy of evidence [20].
Selection process
One reviewer (JT) independently screened titles and
abstracts against the selection criteria, removing duplicates.
Those rejected were reviewed by a second author (VC) to
reduce the exclusion of potentially relevant publications
[21]. Disagreements were discussed and ﬁnal inclusion was
determined after full-text review.
Data extraction and quality assessment
Data extraction was performed independently by two
reviewers (JT and VC) using a predeﬁned template.
Abstracted data included demographics, intervention details,
outcome measures and ﬁndings. Protocols or further detail
from the study authors were sought wherever possible.
The methodological risk of bias was independently
assessed in accordance with the Cochrane Handbook
[22] and the guidelines of the Cochrane Consumers and
Communication Review Group [23]. Five domains were
rated: random sequence generation, allocation sequence
concealment, blinding (outcome assessment), completeness
of outcome data and selective reporting. Performance bias
was not assessed because blinding of participants and
intervention personnel would be impossible.
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Table 1. Taxonomy of discharge interventions [4] adapted by the reviewers for medication continuity
Medication-related activity component Description
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Follow-up
Telephone Use of a telephone or videophone for provider-initiated communication after discharge that does
not occur in the control arm
Home visit Physical visit by intervention provider to patient’s place of residence when this does not happen
in the control arm
Patient education Patient-directed education related to medication but not focused on encouraging
self-management and not occurring in the control arm
Self-management (education or coaching) Patient-directed education or coaching directly focused on improving the patient’s ability to
self-manage their medication needs that does not happen in the control arm
Medication intervention: reconciliation Creating the most accurate list possible of all medications a patient is taking and comparing it to
the current order, with the goal of providing correct medications at all transition points when
this does not happen or is performed by usual care staﬀ in the control arm
Medication intervention: review Critical examination of a patient’s medication with the objective of reaching an agreement with
the patient about treatment optimisation when this does not happen in the control arm
Patient-centred discharge document Some diﬀerence in the format or usability of discharge materials to make them more relevant or
accessible when compared to the control arm
Collaboration within care team Healthcare professionals cooperatively working together, sharing responsibility for
problem-solving and making decisions to carry out medication-related plans for patient care
Timely cross-sector communication Engagement with other sector provider in communication about patient medication status when
this does not occur or occurs at a later date in the control arm
Patient hotline Presence of an open line for patient-initiated communication when this either does not exist in
the control arm or is more restricted in availability or usefulness
Data synthesis and analysis
Information was used to form a description of the interven-
tion components each patient received (when, how often and
for how long).These activities were coded independently (JT
and VC), guided by an adapted version of Leppin et al .’s
taxonomy of interventional activities [15], modiﬁed by the
reviewers for medication-related activities (see Table 1). Dis-
agreements were resolved through discussion. Meta-analysis
of all-cause readmission data was performed (where the risk
ratio (RR) and 95% conﬁdence intervals (CIs) could be
calculated) using the longest reported follow-up period.Out-
come eﬀects were pooled using a Mantel–Haenszel random-
eﬀects model in Cochrane Review Manager (RevMan) V5.3
software. The I 2 statistic was calculated to describe the per-
centage of variation due to heterogeneity rather than chance
and publication bias was assessed. No other outcome data
could be pooled due to variance in reporting measures.
Results
Study inclusion
The search identiﬁed 2394 unique citations. A total of 2278
were excluded following title and abstract review. Full-text
publications were assessed for 116 studies, resulting in 24
that met the selection criteria (see Figure 1). Consensus
between reviewers was 94% with no studies excluded.
Study characteristics
Studies were conducted in 12 countries covering a range
of public and privately funded healthcare systems (see
Figure 2 for summary of characteristics). A total of 17,664
participants were enrolled (range, 25 [24]–4656 participants
[25]) and the sample’s mean age ranged from 66 [26, 27]
to 86 years [28] (Supplementary Material A3 provides full
study characteristics).
Nine studies described intervention bundles provided
during hospital admission [25, 27, 29–35], seven of
which were delivered by the inpatient pharmacy team
and one by geriatricians [34]. One involved an electronic
intervention [25]. Intervention components were most often
delivered once during the inpatient stay. Nine interventions
were commenced during admission and continued post-
discharge, bridging the transition [26, 28, 36–42]. Five
of these involved nurse-delivered interventions, sometimes
acting as ‘transition coaches’, to facilitate the patient’s role
in self-care. Three were pharmacist-led [28, 38, 42] and one
was multidisciplinary [41]. A further six studies evaluated
interventions that commenced post-discharge [24, 43–47],
of which ﬁve were delivered by pharmacists. One study [45]
involved automatic electronic transfer of patient information
to the primary care provider. Overall, intervention delivery
ranged from a single time point to 12months post-discharge.
Themost intensive activity period was between discharge and
3 months post-discharge.
Risk of bias
Twelve studies scored low in all ﬁve risks of bias domains
[24, 25, 28, 34, 35, 38, 41, 42, 44–47] (see Supplementary
Material A4). Nine studies were rated as having the highest
risk of bias [26, 27, 29, 31, 33, 37, 39, 40, 43] based on ran-
domisation and allocation concealment methods. High risk
of bias was found mainly in blinding of outcome assessments
(n = 7 studies).
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Figure 1. PRISMA ﬂow diagram of literature search and
included studies.
Intervention component characteristics
Supplementary Material A5 summarises the medication-
related activity components coded within each study using
the adapted taxonomy. Inter-rater agreement was high
(k = 0.77).
Studies used varying numbers and combinations of activ-
ities within intervention bundles. Most studies utilised three
or more activities (mean = 4.6; range 1–8). Three studies
involved single-component interventions [27, 30, 45]. The
range of time to ﬁrst post-discharge activity was 2 days to
2 months.
Interventions offered during hospital admission
Table 2 shows that the most commonly reported activities
were patient education (n = 5; 56%), reconciliation (n = 6;
67%), provision of patient-centred documentation (n = 4;
66%) and timely cross-sector communication (n = 7; 78%).
Two studies showed a reduction in hospital readmissions
[33, 34] whilst Basger et al . [29] demonstrated a statistically
signiﬁcant diﬀerence within the vitality domain of the
Health-related QoLmeasure. All three of these interventions
included medication review and reconciliation, patient
education and transfer of information; however, only
Legrain et al .’s study [34] was considered to be at low
risk of bias. Discrepancies in medication were improved by
Hockly et al .’s intervention involving transfer of discharge
information (P = 0.00034) [27], Tamblyn et al .’s medication
reconciliation intervention (odds ratio [OR] 0.24; CIs 0.12–
0.57) [25] and Bolas et al .’s intervention (P < 0.005) [31]
involving education and a personalised medication sheet.
Only Tamblyn et al .’s study [25] was considered to be high
quality, with the other studies having selection or detection
biases.
Interventions commenced during hospital admission and include
continuing support post-discharge
The most widely used activity was patient education (n = 9;
100%) (see Table 2).Three studies provided education once,
Casas et al . provided a two hour educational programme
at discharge [37], Huang et al . a medication safety infor-
mation brochure [40] and Ravn-Nielsen et al . used a 30-
min motivational interview [42]. Two studies utilised ‘tran-
sition coaches’ to deliver education throughout follow-up
[36, 39]. Three studies provided education at admission
and discharge using pharmacists (to advise on medication
changes) or nurses (to advise on chronic conditions) [28, 38,
41]. One study [26] provided disease-speciﬁc education in
the participant’s native language. Medication reconciliation
(n = 7; 78%) and patient-centred discharge documentation
(n = 5; 63%), such as a ‘personal health record’ containing
medication information [39], were also used. Post-discharge
telephone calls (n = 5) to provide reinforcement of self-
management [37, 39], further education [26, 38, 40, 42]
and assessment of adherence [28, 41], were conducted more
frequently than home visits (n = 1). Three studies [39–41]
used both methods, conducting a home visit within the ﬁrst
week post-discharge and subsequent weekly telephone calls.
Five of these studies demonstrated a statistically signiﬁ-
cant reduction in all-cause hospital readmissions
[37–40, 42]. All ﬁve interventions included follow-up
(telephone, home visit or both) and education, continuing
until seven [38] to 180 days post-discharge [42]. Four of
these studies [26, 37, 39, 40] were considered to be at the
highest risk of bias, however, as allocation was not concealed
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Figure 2. Eﬀect of intervention activity component compared with usual care on all-cause hospital readmission (a summary of ﬁve
activity components).
or outcome assessors were not blinded. Chan et al . [26]
did not ﬁnd any diﬀerence between arms with the Care
TransitionsMeasure-3 score, which assesses the quality of the
transitional care experience (P = 0.18); however, Huang et al .
[40] found a greater improvement in QoL score within their
intervention arm (I: +18.6 versus C: +15.3; P < 0.001).
Interventions commenced post-discharge
The majority of post-discharge interventions were provided
by pharmacy staﬀ (n = 5): community pharmacists [43]; out-
patient polyclinic pharmacists [46]; and trained intervention
pharmacists [24, 44, 47]. Table 2 shows that medication
reconciliation and medication review were provided in most
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of the intervention bundles (n = 4; 66%). Home visits (n = 4)
were conducted more frequently than telephone calls (n = 1).
Of the six interventions, none showed a statistically signif-
icant reduction in hospital readmission and all were consid-
ered to be high quality. Holland et al . demonstrated a 30%
increase in readmission rates (P = 0.009) in their intervention
arm [47], involving review and education, and a decrease
in visual analogue QoL scores (I: −7.36 versus C: −3.24;
P = 0.042). Other studies reported a reduction inMRPs [48]
(not statistically signiﬁcant) and improvement in medication
discrepancies (P < 0.001) [46] by using pharmacists for
post-discharge review or reconciliation.
Meta-analysis
Nineteen studies reported hospital readmission data and
were therefore combined using meta-analysis (Figure 2) (see
Supplementary Material A6 for full forest plot). One could
not be included [31] as the results were reported in a way that
did not allow calculation of RR. Signiﬁcant variability across
studies was observed (I 2 = 70%).Themeta-analysis, stratiﬁed
by component, demonstrated that the activities associated
with reduced hospital readmissions were self-management
education or coaching (RR 0.81 [0.74, 0.89]), telephone
follow-up (RR 0.84 [0.73, 0.97]) and medication reconcili-
ation (RR 0.88 [0.81, 0.96]). Other components that were
close to statistical signiﬁcance were patient-centred discharge
documents (RR 0.85 [0.70, 1.02]) and education (RR 0.91
[0.80, 1.03]. There was no evidence of publication bias (see
Supplementary Material A7).
Discussion
This systematic review aimed to evaluate the evidence for
interventions that support successful transitions of care for
older people through enhanced medication continuity. We
found interventions that bridged the transition for up to
90 days were more likely to support successful transitions
and reduce adverse outcomes. These interventions used on
average more components than those focusing solely on hos-
pital admission or post-discharge time periods (6.2 versus 3.6
versus 3.8 respectively), reﬂecting their higher intensity and
longitudinal nature. Other reviews of discharge interventions
have shown that multiple components are signiﬁcantly more
eﬀective than a single activity [16, 49–51] and that their
eﬀects are sustained [49]. Actual time taken to deliver the
intervention components was rarely reported, but is impor-
tant to consider in the context of busy healthcare settings.
For example, Ravn-Nielsen et al . [42] reported an average of
114 min spent per patient. The longer term sustainability of
resource intensive interventions such as these and how they
can be integrated into ‘usual care’ should be deliberated.
In this review, patient education, reconciliation and
timely cross-sector communication were the most widely
used activities. Reconciliation, performed manually or via
electronic intervention, was shown to signiﬁcantly reduce
hospital readmission (RR 0.88 [0.81, 0.96]) and was linked
to fewer medication errors [25, 29, 31, 48]. The beneﬁts
of reconciliation appear highly contested in the literature.
When provided after hospital discharge, reconciliation has
not been shown to eﬀectively reduce post-discharge harm
or improve health outcomes [52]. However, reconciliation
provided during admission has demonstrated a reduction in
healthcare utilisation and improved patient safety [53, 54].
Interventions in this review were delivered by a range
of healthcare professionals, with no professional appearing
more eﬀective than the other. Ten studies [33, 34, 37, 40–
44, 46, 47] also involved caregivers; mostly as an infor-
mation source during reconciliation activities. Caregivers
often support older patients during their day-to-day health
management and can eﬀectively promote self-management
[55]. They could, therefore, be engaged in wider activities
amongst these interventions and further work should iden-
tify opportunities for caregiver involvement within medica-
tion continuity.
The most eﬀective component within these interven-
tion bundles was self-management coaching or education.
Promoting self-management in older patients has received
global attention as it is thought to improve a patient’s ability
to manage their long-term conditions. Despite this, self-
management activities were used in less than half of included
studies (n = 8). It is known that older people with low levels
of social, cognitive, and physical functioning are generally
poorer self-managers [56]. Therefore, how such individuals
are supported to self-manage their medication through inter-
ventions such as these requires further attention.
Telephone follow-up (RR 0.84 [0.73, 0.97]) also reached
statistical signiﬁcance within our meta-analysis. Other
reviews of telephone follow-up interventions [57–59] have
been unable to demonstrate a reduction in readmission
rates; however Crocker et al . [57] highlighted that patient
engagement with post-discharge clinical contact was
improved.This contact may, therefore, provide opportunities
for reinforcement of educational messages and resolution of
MRPs; however, barriers to implementation (e.g. time, cost
and personnel resourcing) may limit its use. Patient-centred
health documentation has practical and psychological
beneﬁts for patients, such as bolstering memory, as a tool
for sharing information or feeling more empowered to ask
health-related questions [60].Within our review, it is unclear
how patients made use of their personalised documentation;
however, all examples included an up-to-date list of their
medications presented in an acceptable format.
There is consensus that timely cross-sector communica-
tion supports medication continuity at transitions [50, 61].
Although much emphasis has been given to improving com-
munication at transitions [62], our meta-analysis did not
ﬁnd a signiﬁcant eﬀect on readmission rates (RR 0.90 [0.79,
1.02]). There have been technological advances to support
timely communication and many of the included studies
transferred information to the primary care provider, com-
munity pharmacy or outpatient services at discharge. Spe-
ciﬁc methods included as follows: fax [25, 27, 31–33, 38],
telephone [34, 42], email [26] and secure electronic platform
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[24, 37, 45].We found no interventions describing amethod
allowing primary care providers to readily communicate back
to hospital providers. This is a barrier to medication conti-
nuity within the UK primary care sector when clariﬁcation
or further information is required [61]. Further studies are
needed to test interventions supporting this aspect of cross-
sector communication.
Limitations
Studies were highly heterogeneous, drawn from varying pop-
ulations, care settings and included diﬀerent combinations
of components and delivery time points. It is diﬃcult to
attribute success to individual components within bundles
and our meta-analysis illustrates a modest overall eﬀect size.
Therefore, these results cannot demonstrate causality and we
cannot draw ﬁrm conclusions.There is currently no validated
medication continuity-related measure, which would have
allowed us to better combine results. Three potential studies
were also excluded due to English language restrictions and
unavailability of full-texts.
Coding intervention components can be a highly sub-
jective process [63]. We used our best judgement, espe-
cially when intervention descriptions were lacking detail. To
reduce bias, two reviewers independently coded the com-
ponents. Interventions were only coded if the activity was
explicitly stated.
Most of the included studies contained methodological
ﬂaws, which aﬀected their risk of bias assessment. It was
unclear whether appropriate methods were in fact utilised
and not reported or simply not performed at all. To improve
future trials, studies must ensure absolute blinding of out-
come assessors and that allocation concealment and ran-
domisation are appropriately performed and documented.
Conclusion
Overall, our results suggest that interventions that bridge
the care transition best support older patients’ medication
continuity and have the greatest impact on reducing hospital
readmission. Interventions that included self-management,
telephone follow-up and medication reconciliation activities
were most likely to be eﬀective. Further work needs to
identify how best to engage with patients and their care-
givers in order to better support post-discharge medication
continuity.
Supplementary data Supplementary data mentioned in the
text are available to subscribers in Age and Ageing online.
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